Trxade Group (NASDAQ: MEDS), through its telehealth subsidiary Bonum Health, has signed a strategic agreement with KPH Healthcare Services (“KPH”), a leading pharmaceutical and healthcare services provider, to provide affordable telemedicine services to two KPH divisions. Trxade, an integrated drug procurement, delivery and healthcare platform, will work through Bonum to serve the patients of approximately 100…
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has been granted a patent by the Korean Intellectual Property Office (“KIPO”) for one of its treatments for depression. VistaGen received notification that KIPO…
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a research report by the Benchmark Company LLC. The report, titled “Processa Pharmaceuticals Inc. (PCSA) Processing Assets to the FDA; Initiate at Buy,” lists a $15 price…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently reported its third-quarter financial results and provided a business update, which included initial expectations for 2021 (https://ibn.fm/8PNFi). Among the updates, the Q3 2020 Form 10-Q financial report outlines measurable progress in three important areas: key operational…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today sent a letter to shareholders regarding its virtual special meeting of stockholders, originally scheduled for Dec. 1, 2020, which will be reconvened to 3 p.m. CST on Dec. 30, 2020. According to the update, POAI’s…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently appeared on Gamechangers LIVE, a podcast series that shines a spotlight on gamechangers in various industries, sharing perspective on journeys, mindsets, struggles and successes in an effort to…
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, recently announced a corporate update and financial results for the quarter ended Sept. 30, 2020 (https://ibn.fm/CEDLQ). In addition to being debt free, Energy Fuels had working capital of $44.7 million at the end of Q3 2020, which is a…
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced the launch of Trxade Prime, a revolutionary service offered by the company’s Integra Pharma Solutions subsidiary. According to the update, Trxade Prime solves a historic problem for independent pharmacies suffering from an already complex prescription distribution process. The solution allows…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, is advancing a drug candidate it hopes will beat the deadly brain cancer Glioblastoma Multiforme (“GBM”). The company recently announced that its submission of an Investigational New Drug (“IND”)…
Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Through its subsidiary Soluble Biotech, the company delivers a solution that reduces the cost, time and manpower needed to optimize therapeutic formulations. A recent article discussing this reads, “HSC Technology is…
Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary creator platform, today announced that it has converted its 10,000th freemium creator to a paid Vocal+ subscriber, a milestone achieved several weeks ahead of management’s year-end target. According to the update, Creatd has expanded its Vocal+ premium subscriber base by over 33% in the last…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has reached a significant milestone. The company successfully completed the technology transfer of its manufacturing process for the production of its lead candidate for immunogene therapy, REQORSA(TM). The transfer was made from the major cancer research institution…
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its president and CEO, Richard Wright, is scheduled to present in two virtual investor conferences during December 2020. According to the update, Wright will participate in various one-on-one meetings with institutional…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), recently announced that another casino in Southern California signed an agreement with Knightscope to add a K5 ASR to its staff. According to the update, the K5 ASR will be utilized in an effort to expand the casino’s security program and…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, today announced that Shaquille O’Neal and Brock Pierce will be the keynote speakers at the 13th Annual LD Micro Main Event, a prominent 2-day virtual investor conference. The event will be held via SRAX’s Sequire Virtual Events…
Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that the European Commission, through the Horizon 2020 framework program, has awarded a funding grant of nearly 20 million Euro for the All Weather Autonomous Real logistics operations and Demonstrations (“AWARD”) consortium to develop and operate safe autonomous heavy-duty vehicles…
180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will participate in the LD Micro Virtual Main Event 2020 Conference. According to the update, 180 Life…
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will present at the Benzinga Global Small Cap Conference taking place virtually on Dec. 8-9, 2020. Genprex’s president and CEO, Rodney Varner, will deliver a company overview that includes recent progress the company has made on its…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that it will participate in a fireside chat hosted by IPO Edge in partnership with The Palm Beach Hedge Fund Association, a Florida trade association for financial professionals and ultra-high-net-worth investors. The chat, titled “Security Robots of the Future,”…
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced an expanded partnership with KeHE, which now includes the A88CBD(TM) topical products, A88 Infused(TM) flavors and the entire Alkaline88(R) line, including eco-friendly aluminum bottles. “KeHE has been an exceptional partner in our…